“I am excited to join AVAVA’s Board of Directors and work with a team committed to advancing the next generation of ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its position as a regional leader in advanced ...

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

RIYADH, Saudi Arabia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Saudi hospitals have made significant strides in the 2025 Brand Finance global ranking of the world’s Top 250 hospitals, with seven Saudi ...

Harold’s financial expertise and leadership in scaling up high-growth, healthcare companies are an invaluable addition to ...

CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United ...

ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of ...

LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a ...

Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond, Indiana RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- ...

DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, ...